All Reports Events Blogs Videos
Showing 9 results
  • Tech Launch Perspective
    Sep. 21, 2026

    Life sciences organizations are seeking to reduce study startup timelines, improve clinical data readiness, identify trial risks earlier, and apply AI within regulated workflows. Medidata Plus addresses these priorities through a portfolio-wide clinical AI layer that…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • PEAK Matrix®
    Nov. 25, 2025

    With global and adaptive clinical trials’ rising complexities, life sciences organizations are increasingly adopting intelligent Randomization and Trial Supply Management (RTSM) platforms to enhance operational efficiency, ensure regulatory compliance, and safeguard patient integrity. RTSM systems have…
  • R&D Strategic Technology Outlook
    Aug. 27, 2026

    The biomanufacturing landscape is shifting from fixed process settings, periodic sampling, and end-point testing toward real-time, data-driven process control. The growing complexity of biologics, cell and gene therapies, mRNA therapeutics, and antibody-drug conjugates is increasing the…
  • Provider Compendium
    Dec. 17, 2025

    Life sciences organizations are increasingly prioritizing automation, configurability, and real-time visibility to support modern clinical trial requirements. As adaptive designs, decentralized models, and global multi-protocol studies become more prevalent, the role of Randomization and Trial Supply…
  • PEAK Matrix®
    Sep. 01, 2025

    eCOA solutions are transforming clinical trials by enabling accurate, real-time capture of patient, clinician, and caregiver-reported outcomes through smartphones, tablets, web portals, and provisioned devices. These platforms are redefining how clinical trials capture participant-reported data by…
  • Tech Provider Spotlight
    Oct. 14, 2025

    Clinical trial complexity continues to increase with hybrid study models, diverse data sources, and growing regulatory expectations, making traditional oversight models inadequate. Conventional monitoring approaches reliant on 100% source data verification and frequent on-site visits are…
  • Provider Compendium
    Nov. 25, 2025

    Life sciences enterprises are accelerating their shift to modern digital platforms to meet evolving demands for agility, patient-centricity, and regulatory compliance. Traditional ERP and CRM systems are giving way to cloud-based platforms that enable intelligent, connected…
  • PEAK Matrix®
    July 22, 2016

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…